Hodi FS, O'Day SJ, McDermott DF et al : Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 363 (8) : 711-723, 2010.
Robert C, Thomas L, Bondarenko I et al : Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med 364 (26) : 2517-2526, 2011.
Topalian SL, Hodi FS, Brahmer JR et al : Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 366 (26) : 2443-2454, 2012.